ACTIVITY OF THYME OIL (OLEUM THYMI) AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII AND PSEUDOMONAS AERUGINOSA

被引:0
|
作者
Trojanowska, Danuta [1 ]
Paluchowska, Paulina [1 ]
Soja, Lukasz [1 ]
Budak, Alicja [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Fac Pharm, Dept Pharmaceut Microbiol, 9 Medyczna St, PL-30688 Krakow, Poland
来源
ACTA POLONIAE PHARMACEUTICA | 2016年 / 73卷 / 04期
关键词
thyme oil; activity; non-fermenting bacilli; multidrug-resistant strains;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Almost as soon as antibiotics were introduced to treat infectious diseases. it could be observed that bacteria were able to develop resistance against them. Currently, multidrug-resistant strains are being isolated mainly in the hospital environment. These are primarily non-fennenting Gram-negative bacilli, which exhibit both natural and acquired resistance to multiple antibiotics and disinfectants rendering them difficult to eradicate. The development of new, effective and safe substances that prevent troublesome infections is greatly needed to provide alternative therapeutic options for patients. There is increasing interest in drugs of natural origin. including essential oils. It is of particular interest that. although active against many bacterial strains, they do not contribute to antibacterial resistance against their components. The aim of our study was to evaluate the in vitro antibacterial activity of thyme oil against multidrug-resistant strains of A. baumannii and P. aeruginosa using the disc diffusion and macrodilution methods. The strains were isolated from patients hospitalized in the years 2013-2014. The in vitro antibacterial activity of thyme oil was assessed by the disc diffusion method and the inhibition zones for the oil at different concentrations, produced against A. baumannii, ranged from 7 to 44 mm. Low level of activity of thyme oil was observed against P. aerugionsa strains. The results of serial dilution tests confirmed the high activity of thyme oil against A. baumannii isolates, expressed as MIC values ranging from 0.25 to 2 mu L/mL. These results suggest the need for further studies of antibacterial activity of essential oils, especially against multidrug-resistant bacterial isolates.
引用
收藏
页码:975 / 981
页数:7
相关论文
共 50 条
  • [31] Antimicrobial combination effects against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa strains: A cross-sectional study
    Kazemian, Hossein
    Karami-Zarandi, Morteza
    Heidari, Hamid
    Ghanavati, Roya
    Khoshnood, Saeed
    HEALTH SCIENCE REPORTS, 2024, 7 (05)
  • [32] Synergistic antibacterial activity of curcumin and phage against multidrug-resistant Acinetobacter baumannii
    Janesomboon, Sujintana
    Sawaengwong, Thanchanok
    Muangsombut, Veerachat
    Vanaporn, Muthita
    Santanirand, Pitak
    Kritsiriwuthinan, Kanyanan
    Gundogdu, Ozan
    Chantratita, Narisara
    Nale, Janet Yakubu
    Korbsrisate, Sunee
    Withatanung, Patoo
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [33] In vitro antimicrobial activity of tigecycline against multidrug-resistant Acinetobacter baumannii strains
    Azap, O. Kurt
    Timurkaynak, F.
    Karaman, S.
    Arslan, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S588 - S588
  • [34] In vitro antibacterial activity of eravacycline against multidrug-resistant Acinetobacter baumannii isolates
    Ataman, Merve
    Mataraci-Kara, Emel
    Ozbek-Celik, Berna
    JOURNAL OF RESEARCH IN PHARMACY, 2021, 25 (05): : 549 - 553
  • [35] Multidrug-Resistant Acinetobacter baumannii mediastinitis
    Dumani, Selman
    Puca, Edmond
    Likaj, Ermal
    Llazo, Stavri
    Rruci, Edlira
    Beca, Vera
    Refatllari, Ali
    Baboci, Arben
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (07): : 1132 - 1134
  • [36] Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin
    A. Safarika
    I. Galani
    A. Pistiki
    E. J. Giamarellos-Bourboulis
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 317 - 323
  • [37] Multidrug-Resistant Acinetobacter baumannii in Jordan
    Al-Tamimi, Mohammad
    Albalawi, Hadeel
    Alkhawaldeh, Mohamd
    Alazzam, Abdullah
    Ramadan, Hassan
    Altalalwah, Majd
    Alma'aitah, Ahmad
    Al Balawi, Dua'a
    Shalabi, Sharif
    Abu-Raideh, Jumana
    Khasawneh, Ashraf, I
    Alhaj, Farah
    Hijawi, Kamal
    MICROORGANISMS, 2022, 10 (05)
  • [38] Multidrug-resistant Acinetobacter baumannii, Russia
    Naas, Thierry
    Kernbaum, Serge
    Allali, Sophie
    Nordmann, Patrice
    EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 669 - 671
  • [39] The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
    Mwangi, James
    Yin, Yizhu
    Wang, Gan
    Yang, Min
    Li, Ya
    Zhang, Zhiye
    Lai, Ren
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (52) : 26516 - 26522
  • [40] Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro
    Kroeger, Lisa A.
    Hovde, Laurie B.
    Mitropoulos, Isaac F.
    Schafer, Jeremy
    Rotschafer, John C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) : 3431 - 3433